|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 31/519 | (2006.01) |
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 1750716 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05756183.9 |
| Date of filing the European patent application | 2005-05-31 | |
| (97) | Date of publication of the European application | 2007-02-14 |
| (45) | Date of publication and mention of the grant of the patent | 2008-08-20 |
| (46) | Date of publication of the claims translation | 2009-01-26 |
| (86) | Number | PCT/US2005/019169 |
| Date | 2005-05-31 |
| (87) | Number | WO 2005/117891 |
| Date | 2005-12-15 |
| (30) | Number | Date | Country code |
| 521593 P | 2004-05-30 | US |
| (72) |
O`CONNOR, Owen, A., US
SIROTNAK, Francis, US
|
| (73) |
Sloan-Kettering Institute For Cancer Research,
1275 York Avenue, New York, New York 10021,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | T ląstelių limfomos gydymas, naudojant 10-propargil-10-deazaaminopteriną |
| TREATMENT OF T-CELL LYMPHOMA USING 10-PROPARGYL-10-DEAZAAMINOPTERIN |
| Payment date | Validity (years) | Amount | |
| 2024-05-02 | 347.00 EUR |